|
|
|
 | Biomarkers: An Indispensible Addition to the Drug Development Toolkit Examining the Potential of Biomarkers Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents. Discover the potential of biomarkers to: - Improve decision making
- Accelerate drug development
- Reduce development costs
|  | Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses: - The information technology challenges of gene sequencing
- “Intelligent” methods for data management and customization
- System survival tips... Deciding what data to keep or delete
- New tools to keep scientists ahead of impending data torrents
|  | Managed Innovation, Assured Compliance Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.
|  | What’s Wrong with Biomarkers? The hype around biomarkers has reached such a fever pitch that it risks provoking a backlash among needed constituencies such as payers, physicians, and patients. No one doubts biomarkers’ long-term value, but many obstacles remain, and that time still seems distant. Read this in-depth analysis in which distinguished experts examine biomarker challenges and follow along as they: - Identify the need for change in research and clinical trial strategies
- Concede biology is more complicated than first expected
- Explore barriers to physician adoption of biomarkers
- Review assay technology and sample access limitations
- Examine nascent efforts to develop needed standards
- Discuss some notable biomarker failures and their lingering impact
- Tackle thorny commercialization issue holding back biomarkers
| .jpg) | Protecting Intellectual Property Intellectual property (IP) remains one of the most important assets of any commercial entity. Historically, paper has been used to establish, maintain and defend IP, but as industry becomes increasingly digital, new tools must be used to ensure IP protection. In this white paper we explore the issues facing patent creation and defense in the electronic age and discuss the tools and functionality required to protect innovation.
|  | Leveraging Text-Mining Based Search to Navigate Biomedical Literature With the amount of research data available today estimated at 18 million documents across more than 20,000 medical journals, it is more important than ever that students, researchers, professionals, doctors, and librarians have easy access to the latest research information available. This paper discusses: - The pros and cons of various ways in which to search biomedical information, such as text mining, natural language processing, information extraction and knowledge discovery.
- How novo|seek – a new biomedical search engine that takes into account context of biomedical terms to define its meaning - leverages text mining to offer an easy to use, and efficient search system for biomedical literature and grant information.
|  | Translational Research Briefing ON Report The varied collection of Bio-IT World articles and insights assembled in this Briefing ON examines: - The impact of integrating clinical data back into the research and development pipeline.
- Using information gathered from physical samples, databases, and clinical trials to benefit the design and performance of future research.
|  | Reducing bottlenecks in GMP Laboratories Significant time is spent conducting quality control (QC) testing and documenting QC results during the pharmaceutical manufacturing process. GMP regulations require maintaining documentation to ensure strict compliance with established SOP’s. Completing paper documents and ensuring their authenticity creates a bottleneck in the QC laboratory. Waters® NuGenesis® SDMS Intelligent Procedure Manager, an electronic SOP workflow & documentation system, addresses the predominately manual activities required to perform an analytical method. Cycle times are reduced up to 50-75% as compared to a traditional paper trail thereby boosting productivity and accuracy. |  | Coherent IT Strategy for Fast-Moving R&D Putting value on an IT strategy is easier with an end-to-end view, from target to market, of the cause and effect of good and bad information and decisions. This forges the essential link between science, information, IT and business funding of the IT investment. This paper seeks to:
- Help biopharm companies build effective IT for R&D strategies.
- Deploy highly relevant systems around a particular set of goals.
- Discuss case studies where this approach has returned better business value.
|  | A Rapidly Deployable Data Management System for Clinical Research The Statistical Center for HIV/AIDS Research and Prevention (SCHARP) statisticians and internal IT staff created an Integrated Data Management System for Clinical Research working closely with open-source LabKey Server systems. The system enables collaborators to more rapidly: - Analyze
- Validate
- Share datasets from labs and clinics around the world, as they are collected.
Learn more about this system, and how it can be rapidly deployed. | .jpg) | Applications of LIMS for Enhanced Productivity in Translational Discovery Research Translational research can improve the effectiveness of drug research and target discovery pursuits. However, managing the massive amounts of data has posed enormous challenges for –omics and biorepository labs. This white paper discusses the latest developments in translational research and describes how an adaptive data infrastructure and a flexible Lab Information Management Solution (LIMS) framework can be pivotal for successful Translational Research.
|  | Adobe® LiveCycle® ES Deploying Adobe Technology to Automate Electronic Submissions Discover how to:
- Help reduce the cost of bringing products to market
- Improve document collaboration across your organization
- Satisfy global regulatory requirements, stockholder expectations, and customer demands
- Improve data capture, information assurance, document output, process management, and content services
- Gain a competitive advantage, get immediate ROI
|
Biomarkers: An Indispensible Addition to the Drug Development Toolkit Examining the Potential of Biomarkers Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents. Discover the potential of biomarkers to: - Improve decision making
- Accelerate drug development
- Reduce development costs
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses: - The information technology challenges of gene sequencing
- “Intelligent” methods for data management and customization
- System survival tips... Deciding what data to keep or delete
- New tools to keep scientists ahead of impending data torrents
Managed Innovation, Assured Compliance Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.
Presented by Trade Commission of Spain
Spain Biotech: An Engine for Economic Change
 Discover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.
Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.
Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.
Access the podcast
More Podcasts
MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING (Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland. In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required. PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience. View complete job posting & apply: www.saic-frederick.com. Position #146945.
|
|
|